North American Neuromodulation Society

Clinical Trial Design Standards

 

The Clinical Trial Design Standards Committee will provide expertise for ensuring high standards in neuromodulation research and trial design. It will ensure proper review of the technology and science to ensure future study designs will be of the highest clinical and cost-benefit merit to advance the field and ensure proper reimbursement by the healthcare system.

Brian Kopell, MD (co-chair)

Salim Hayek, MD PhD (co-chair)

Lawrence Poree, MD PhD
Nathaniel Katz, PhD
John Markman, MD
Richard North, MD

Rod Taylor, PhD

Sam Eldabe, MB ChB FRCA FFPMRCA

Steve Falowski, MD 

Vibhor Krishna, MD SM

The Clinical Trial Committee of IoN has been engaged in producing publications that guide future neuromodulation studies, focusing first on spinal cord stimulation (SCS). Historically, neuromodulation studies have been hindered by several factors including difficulty of blinding participants, cost, industry sponsorship, lack of appropriate controls… To address these issues, NANS/IoN has collaborated with the International Neuromodulation Society (INS) and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), and several publications have resulted. The first three systematically reviewed and analyzed published SCS prospective studies, their reporting quality, and the use of sham and placebo controls. The fourth and most recent manuscript expanded on research considerations in designing future SCS studies and set forth detailed recommendations. 

Duarte, R.V. et al., 2020: Randomized Placebo‐/Sham‐Controlled Trials of Spinal Cord Stimulation: A Systematic Review and Methodological Appraisal. Neuromodulation. doi:10.1111/ner.13018

Next, the Clinical Committee of IoN will explore design, costs and barriers of prospective studies examining efficacy of neuromodulation approaches compared to other standard therapies.

Contains 0 items
Subtotal: $0.00



WIKISTIM

WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

NANS Events   

  • Jan. 13-15, 2022

    NANS 25th Annual Meeting
    Walt Disney World Swan & Dolphin Resort
    Orlando, FL
    Learn more.

Contains 0 items
Subtotal: $0.00